On the contrary, arterial thrombotic events were independently associated with less severe COVID-19 on admission, shorter duration of symptoms, lower CRP, better functional status on admission, higher comorbidity burden, established atherosclerotic disease, aspirin use, and other. The gene discussed is CRP; the disease is COVID-19.